Skip to main content
. 2023 Feb;15(1):45–54. doi: 10.18502/ijm.v15i1.11917

Table 5.

The relation between the presence of ESBLs genes and antibiotics resistance

Gene Isolate n=95 (%) NO. (%) of Antibiotic resistance

CX CTR CTX CAZ FEP AUG A/S PI PIT AT IMI MRP CL GEN AK CIP
bla SHV-2a 21 (22.1) 19 (90) 4 (19) 5 (23) 21 (100) 9 (42) 16 (76) 21 (100) 3 (14) 0 11 (52) 0 0 3 (14) 0 0 1 (4%)
PER 1 (1.05) 1 (100) 0 1 (100) 1 (100) 0 0 1 (100) 1 (100) 1 (100) 1 (100) 1 (100) 1 (100) 0 1 (100) 1 (100) 1 (100%)
SHV + PER 1 (1.05) 1 (100) 1 (100) 0 1 (100) 0 1 (100) 1 (100) 0 0 1 (100) 0 0 0 0 1 (100) 1 (100)
SHV + VEB 2 (2.1) 2 (100) 2 (100) 2 (100) 2 (100) 1 (50) 2 (100) 2 (100) 1 (50) 0 1 (50) 0 0 0 0 0 1 (50)
PER + VEB 1 (1.05) 1 (100) 1 (100) 0 1 (100) 0 0 1 (100) 1 (100) 1 (100) 0 1 (100) 1 (100) 0 1 (100) 1 (100) 1 (100)
SHV + PER + VEB 1 (1.05) 1 (100) 1 (100) 0 1 (100) 0 1 (100) 1 (100) 0 0 1 (100) 0 0 0 0 0 0
bla CTX-M-28 1 (1.05) 1 (100) 1 (100) 1 (100) 1 (100) 1 (100) 1 (100) 1 (100) 1 (100) 1 (100) 1 (100) 1 (100) 1 (100) a0 1 (100) 1 (100) 1 (100)
bla OXA-677 39 (41.05) 39 (100) 38 (97) 39 (100) 39 (100) 37 (94) 38 (97) 39 (100) 38 (97) 39 (100) 39 (100) 39 (100) 39 (100) 1 (2) 39 (100) 39 (100) 39 (100)
OXA-677 + CTX-M-28 17 (17.89) 17 (100) 16 (94) 17 (100) 17 (100) 15 (88) 15 (88) 17 (100) 17 (100) 17 (100) 17 (100) 17 (100) 17 (100) 2 (11) 17 (100) 17 (100) 17 (100)
P value 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001